Jul 8, 2019 | Main Blog, Peptide |
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Oct 3, 2018 | Main Blog |
The drug development model is in need of a drastic shakeup. COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic...
Jun 14, 2017 | Main Blog, Peptide |
Having worked with many pharmaceutical and biotech companies over the last few years as the co-organizer of our annual Controlled & Modified Drug Release Summit, the need for many of them to explore opportunities and invest in controlled release technologies...
Recent Comments